SCHEMBL7541829

SCHEMBL7541829

CC(Nc1nccc(-n2cnc3ccccc32)n1)C1CNCCN1C

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 17/20 0.67
MKNK1 Q9BUB5 3/20 0.58
MKNK2 Q9HBH9 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7103389 0.83 LCK (0.79) LCKMKNK1MKNK2
SCHEMBL7105256 0.83 LCK (0.66) LCKMKNK1MKNK2
SCHEMBL7587843 0.80 LCK (1.00) LCK
SCHEMBL7550282 0.79 LCK (1.00) LCK
SCHEMBL7019366 0.78 LCK (1.00) LCKMKNK1MKNK2
SCHEMBL7019359 0.78 LCK (1.00) LCKMKNK1MKNK2
SCHEMBL7973150 0.77 LCK (0.78) LCKMKNK1MKNK2
SCHEMBL7542352 0.77 LCK (0.68) LCK
SCHEMBL7873119 0.74 LCK (1.00) LCK
SCHEMBL7495391 0.74 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
EP-1140087-A4 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARM CO (US) 2002-04-03 EP disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 US disclosed
EP-1140087-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
WO-2000035454-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARMACEUTICALS COMPANY (US) 2000-06-22 WO disclosed